Eli Lilly | chemanager-online.com - Chemistry and Life Science

Sep. 13, 2019
Topics
Injecting Growth and Innovation
Abbvie takes over Allergan, Pfizer merges its generics business with Mylan, Takeda integrates Shire — the pharmaceutical industry is making a name for itself in 2019 with several billion-dollar acquisitions. This is an attempt to ...
Aug. 23, 2019
News & Opinions
Lilly Wins Alimta Appeal
US pharma company Eli Lilly has won a federal appeals court decision that protects its cancer drug Alimta from generic versions made by Pfizer and Dr. Reddy’s Laboratories.
Jul. 18, 2019
News & Opinions
Bayer and Elanco Animal Health Link-up?
Pharmaceutical market buzz last month had it that private equity investors in Europe and the US were lining up to buy the animal health business Bayer is preparing for sale to pare down debt after its $63 billion takeover of Monsanto in ...
Apr. 30, 2019
News & Opinions
Lilly and Avidity Biosciences Partner on New Drugs
Eli Lilly is collaborating with Avidity Biosciences to discover, develop and commercialize potential new medicines in immunology and other select indications.
Apr. 08, 2019
Topics
The Need for Innovation in Pharmaceutical Manufacturing
The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs ...
Nov. 02, 2018
News & Opinions
DCAT Announces New Board of Directors
Paolo Magri, senior vice president, business development at Advitech, has been elected president of the Drug, Chemical & Associated Technologies Association (DCAT). Also elected to serve as officers of DCAT are: Stephan Kutzer, ...
May. 17, 2018
News & Opinions
Eli Lilly to Buy AurKa Pharma and ARMO
US drugmaker Eli Lilly has agreed to buy Canada’s AurKa Pharma from TVM Capital Life Science, bringing back in-house experimental cancer drug AK-01. The drug, an Aurora kinase A inhibitor, was originally discovered by Lilly, which ...
Jan. 10, 2018
News & Opinions
US Health Secretary Pick Hammered on Price Gouging
Alex Azar, US President Donald’s Trump’s choice to head the Department of Health and Human Services (HHS), has faced from criticism from Democrats in the Senate Finance Committee for the sharp drug price rises he oversaw as ...
Nov. 14, 2017
News & Opinions
Former Lilly President to Head US Health Department
US president, Donald Trump, has chosen Alex Azar, a former US president of drugmaker Eli Lilly, as his new Secretary of Health and Human Services (HHS). Azar will replace Tom Price, a former Congressman from Georgia, who was forced to ...
Oct. 23, 2017
News & Opinions
Lilly and CureVac in Cancer Vaccines Pact
In a deal that could lead to the development of five new cancer vaccines, US drugs giant Eli Lilly is investing in German biopharma CureVac.

12 3 4 5 6 7 8…

Register now!

The latest information directly via newsletter.

GIT Verlag